Table Of Content

Author Index Vol. 40, 1994 SFL OSI LIER PERT BISM e Ee RRL ME Supplement | has its own Author Index (B) = Book Review Abe, M. 418 Chandrasekar, P.H. 136 Gillmore, J.D. 16 Kréméry,V . 72 (B) AbramoffM,. 195 Chandrasekaran,S . 357 Goldstein, E. 404 Kréméry, V., Jr. 70, 209, Ahmad, H. 239 Cheng, D.-L. 384 Gomez,J . 299 287, 431 Ahmed, M.M. 337 Chitra,M . 109 Gomez-Lus, M.L. 99 Kubo, S. 333 Akaboshi, M. 418 Chorvath, B. 51 GooHt., va n der 124 Kukutkova, E. 431 Akahane, K. 412 Close,J . 114 Goto, S. 324 Kumazawa,J . 333 Akuta, K. 418 Cocuzza, C.E. 157,215 Kunii,O . 404 Al-Bekairi, A.M. 188 Cooper,I . 21 Halim, M. 26 Kunming,Y. 61 Al-Gharably, N.M. 188 HaraokaM,. 333 Kusumoto, H. 279 Al-Harbi, M.M. 188, Dal Sasso, M. 37 Hatano, K. 1, 73, 167 337 DaniSovigovaA,. 70, Hel’pianska, L. 431 Lacka, J. 431 Al-Shabanah, O.A. 188 209 Hernandez-Cardona, Lambert-Zechovsky, N. Aoki, M. 404 Das, S. 272 J.L. 299 183 Degré, M. 201 Herrera, I. 99 LanducciM,. 144 Baba, A.A. 357 Demartini, G. 215 Hlavaéova, E. 431 Lang, R. 252 Baba, H. 279 Demertzis, S. 149 Hotz, G. 65 Lanzafame, A. 157 Baltch, A.L. 80, 391 Dermoumi, H. 92 Howard, B.M.A. 232 Lau, A.H. 369 Barko, N. 195 D’Errico, G. 435 HruSkovié, I. 209 Laufs, R. 293 Bazzano, M. 104 Dluholucky, S. 209 Huang, W.-K. 384 Leonhard,B . 374 Beck, S. 201 Dugnani,S . 215 Huffman, J.H. 42 Lepore, A.M. 157 Belan, S. 209 Duraj,J . 51 Hunakova, L. 51 Lipperheide, V. 145 Bengtsson, S. 30 Hussain Qadri, S.M. 26 Liu, Y.-C. 384 Bert, F. 183 Efferth, T. 265 Look, M.P. 8 Bertelli,G . 144 El-Aaser, A.-B.A. 227 Ifrach, N. 252 Lopez-Berestein, G. 256 Blahova, M. 70 El-Merzabani, M.M. Ito, K. 161, 362 Blasi, F. 37 Zar Izumi, K. 161, 362 Maccarinelli,G . 215 Bone Marrow Transplan- Endo, K. 279 Maci, S. 37 tation Team 136 Evans, S.R.T. 348 Jagadeesan, M. 427 McQueen, T.J. 256 Bonfiglio, G. 311 Jain, R. 369 Maehara,Y . 57,279 Braga, P.C. 37, 304 Fasching, C.E. 21 Jaudenes, L. 245 Marinova, I. 209, 287 Brandeburova, O. 287 Ferrara, F. 215 Jayakumar, C.R. 357 Martin, M. 99 Branger, C. 183 Fietta, A. 317 Jesenska, Z. 70 Martinez, P. 99 Brezina, M. 209 FitzloffJ, . 369 Masunaga, S. 418 Brook, I. 16 Fraschini, F. 215 Kaiserova, E. 209 Mathéova, E. 209 Bruneau, B. 183 Freund, M. 149 Kaneko, Y. 324 Matsumoto, T. 333 Buras, R.R. 348 Furneri, P.M. 104 Katoh, N. 161, 362 Mattina, R. 157 Buschiazzo, H. de 221 Kawai, K. 418 Mazzoni, M.P. 435 Buschiazzo, P. de 221 Gaillot, O. 399 Kayserova, H. 209 Mehta, R.T. 256 Butcher, W.G. 114 Gaiova, K. 209 Keyhani,A . 256 Merlini,C . 317 Ganguly,C . 272 Kimura, Y. 412 Mikamo, H. 161, 362 Campo, L. 104 Garg, A.K. 239 Kinzig, M. 65 Mine, Y. 1 Canteras,M . 299 Gatny,C.M. 136 Kitano,Y . 412 Miyashita, H. 404 Capocasale, E. 435 Gerding, D.N. 21 Kohnoe, S. 57 Miyashita, T. 404 Carrillo-Mufioz, A.J. Gialdroni Grassi, G. Kollar, T. 431 Moledina, N. 239 245 317 Krajewska-Pietrasik, D. Moscon, B.J. 42 Cesana, M. 104 Giangreco, A.B. 337 114 Musch, E. 8 Nauta, R.J. 348 Qiong, S. 61 Shah, A.H. 337 Tamaya, T. 161, 362 Neumann, S. 293 Quindés, G. 245 Shanholtzer, C.J. 21 TanakaM,. 333 Nicoletti, G. 311 QuirogaG,. 221 Shasha, B. 252 Tang,I . 369 Nishihara, Y. 167 Qureshi,S . 337 Shchepotin, I.B. 348 Teitz, Y. 195 NishinoT, . 73, 167 Shibl, A.M. 399 Tempera,G . 104 Nishiya,H . 404 Raza, M. 337 Shyamala Devi, C.S. TimmermanH,. 124 Novotny-Lenhard,J . 65 Ritz, W. 80, 391 109, 427 Tinman, S. 252 Nuimiez, M.L. 299 Rodriguez-Escudero, Sidwell, R.W. 42, Tokumura,Y . 404 F.J. 265 290 (B) Tondo, S. 435 Odenholt-Tornqvist, I. Romoli, L. 157 Sinn, L.M. 21 Torres-Rodriguez, J.M. 30 Ronen, D. 195 Smith, J.T. 232 245 OellerichM,. 149 RuanguanW,. 61 Smith, R.P. 80, 391 Traub, W.H. 374 Ohyatsu, I. 404 Rubinstein, E. 252 Sobottka, I. 293 Trupl,J . 431 Okada, Y. 57 Rubio, M. 221 Soergel, F. 65 Tsuji,A . 324 Ono, K. 418 Ruiz-Gomez,J . 299 Soldatenkov, V.A. 348 Tsutomi, Y. 412 Ono, Y. 404 Rule, R. 221 Spanik, S. 70 Orosova, K. 209 Speiser, P. 51 Ueno, K. 161, 362 Osman, A.M. 188 Saad, S.F. 227 Stefani, S. 311 Ueno, Y. 26 Osman, A.-M.M. 227 Saad, S.Y. 227 Studena, M. 431 Othman,N. 357 Saito, A. 57 StudenaV,. 431 Vaira, F. 144 OtsukiM,. 167 Sakamoto,Y . 333 Subramaniam, S. 427 Valdés,M . 299 SakumotoM,. 333 Sufliarsky,J . 431 Vigani, A. 144 Padhye, A.A. 239 Saldin, H. 26 Sugimachi, K. 57,279 Volm, M. 265 Pérez, P. 99 Sdlek, T. 431 Sugiyama, H. 404 Vonkomerova, A. 431 Petersen, D. 149 Salesa, R. 245 Suja, V. 109 Peterson, L.R. 21 San Millan, R. 245 Sukumar, E. 109 Wakai, Y. 1 Piatti, G. 37 Scaglione, F. 215 Sultan, T. 80 Warren, R.P. 42 Pichia, P. 431 Schneider,J . 265 Switalski, L.M. 114 Watanabe, K. 161, 362 Pinney, R.J. 232 Schumann, G. 149 Szabadosova, V. 287 Watanabe, Y. | PontonJ, . 245 Sedlak,J . 51 Willard, K.E. 21 Pronzato, P. 144 Sekhon, A.S. 239 Takagaki, M. 418 Seydel, J.K. 124 Takahashi,I . 57 Yamaguchi, K. 324 ShabahangM,. 348 Takahashi, K. 333 YamamotoM,. 279 Author Index Subject index Voi. 40, 1994 a EI EET L MR ee LOANED IRLL ANE INI | Supplement 1 has its own Subject Index Adhesion 114 Carcinoma 265 Endometrium 265 Agar disk diffusion test 374 CD15 51 Enoxacin 61, 304 Aminoglycoside resistance 391 Cefdinir 73, 80, 232, 317, 362 Erythrocyte membrane lipid 427 Amoxicillin 215 Cefixime 317 Erythromycin 304 Amphotericin 136 Cefodizime 404 Escherichia coli 124 - B 70,92, 239, 256 Cefotaxime 221 Etest 293 Analgesic 109 Cefpirome 311 Etoposide 144 Antibacterial activity 80, 324 Cefpodoxime 114 Antibiotic therapy 61 Ceftibuten 37 FK037 161, 167, 391 Antibiotics 384 Ceftriaxone 61, 65, 435 Fleroxacin 293, 333 Anticarcinogenicity 337 Cephalosporins 80, 384, 391 Fluconazole 92, 136, 239 Antifungal agent 149 Chemiluminescence 37, 333, 404 Flucytosine 149 - susceptibility 245 Chemotaxis 37 5-Flucytosine 287 Anti-inflammatory 109 Chemotherapy 8, 265 5-Fluorocytosine 149, 239 Antimicrobial agents 21 Chlamydia trachomatis 104 5-Fluorouracil 227, 348, 427 — drugs 374 Chloramphenicol 215 Flurithromycin ethylsuccinate - prophylaxis 65 Ciprofloxacin 21, 209, 304 157 - resistance 299 Cis-diamminedichloroplati- Foscarnet 201 Anti-MRSA activity 167 num(II) 418 Fosfomycin 99 Antimycotics 239 Clarithromycin 215, 304 Fungal infections Prophylaxis 136 Antiretrovirus 195 ClIa B-lsactsama se 311 Fungemia 287 Antitumor 109 Clearances 369 Fusarium species 239 Antiviral 42 Clindamycin 16 Fusidic acid 201 Aspergillus fumigatus 92 Clonic convulsion 412 ATB fungus 245 Cloxacillin 114 GABA receptor 412 Aureobasidium mansoni menin- Collaborative study 245 Gastric cancer 57,279 gitis 70 Collagen 114 Glutathione-S-transferase 265 Azithromycin 252, 304 Commiphora molmol 337 Gynecology 161 Comparison of agar media 374 Bacterial adhesion 215 Cyclophosphamide 427 Haemophilus influenzae 299, 399 - adhesiveness 304 Cytokines 51 HBW 538 404 - outer membrane proteins 215 Cytotoxicity interaction 188 Hemodialysis 369 — vaginosis 362 High-performance liquid chroma- Bacteroides fragilis 16 Dalton’s lymphoma 272 tography (HPLC) 8 Bauer-Kirby method 374 Dideoxycytidine 201 High-pressure liquid chromatog- Bilharzial-infested mice 227 Dideoxyinosine 201 raphy 149 Bordetella pertussis 215 Dideoxynucleosides 201 HIV replication 201 Bovine 221 DNA 109 HR 810 311 Breast cancer 427 Dosage individualization 149 Human phagocytic functions 317 - —- celllines 51 Doxorubicin 188 Hyperthermia 188, 348 Brucellosis 252 EGF receptor 51 Iso 124 Cancer 8 Ehrlich ascites 337 Influence of Cu2* ions 124 Candida albicans 124 — cells 188 Influenza virus 42 Capsule 16 Elderly patient 279 Inhibitory concentration 92 Carboplatin 144 Embelin 109 Intracisternal injection 412 In vitro activity 26, 183, 293 Obstetrics 161 Sensitivity 384 antibacterial activity 161, Ofloxacin 21, 61, 209, 333, 412 Serum levels 157 167 Oral cephalosporins 317 Simulation 1 susceptibility 92 Oxacillin 65 Small-particle aerosol 42 Isoquinolines 124 Solid tumors 337 Itraconazole 92, 239 Pancreatic cancer 348 Soybean agglutinin 272 Paranasal sinuses 357 SP-303 42 Josamycin 304 Pefloxacine 431 Sparfloxacin 30 Pericardial effusion 57 Staphylococcus aureus 21, 26, 73, Ketoconazole 239 Peripheral blood lymphocytes 272 114 Klebsiella pneumoniae 324 P-glycoprotein 265 Streptococcus pneumoniae 299 Phagocytes 256 — pyogenes 73 Lactam compounds 324 Phagocytosis 37, 99 Subinhibitory concentrations 30 B-Lactam antibiotics 183 Pharmacokinetics 1, 157,221, Sub-MICs 304 Lactamase 399 227 Susceptibility 16, 399 Lactams 1, 80 Phenanthrolines 124 Legionella pneumophila 104 Phenolic biopolymer 42 Teicoplanin 431 Leukocyte interferon 201 Phytohaemagglutinin 272 Temafloxacin 304 Levofloxacin 412 Pokeweed mitogen 272 Therapeutic drug monitoring 149 Lipid peroxides 8 Polymorphonuclear leukocytes - index 195 Lipopolysaccharide 404 37, 333, 404 Thiobarbituric-acid-reactive Liposomes 256 Postantibiotic effect 30,232 substances (TBARS) 8 Listeria monocytogenes 104 — leukocytic enhancement 99 Thiosemicarbazone derivatives Postoperative chemotherapy 279 195 Macrophages 201, 272 Pristinamycin 99 Tissue cage fluid 221 Magnetic resonance imaging 209 Protective activity 167 Transmission electron microscopy Maxillofacial surgery 65 Protein 109 167 Methicillin 21 Pseudomonas aeruginosa 183, Tumor 357 — resistance 26 324, 391 — necrosis factor-a 404 Methotrexate 227, 427 - spp. 391 Typhoid fever 61 Metronidazole 362 Mezlocillin 65 Quality control strains 374 Urinary tract infection 435 Mice 1 Quiescent cell 418 Miconazole 287 Quinolone 21, 232, 333, 412 Vancomycin 114 Minimal inhibitory concentration Quinolone-associated arthropathy Verapamil 348 124 209 Minocycline 26 Wheat germ agglutinin 272 Miocamycin 304 Radiochemotherapy 357 Wound infection 435 MitomycinC 57 Renal transplantation 435 Moraxella catarrhalis 299 Resistance 21, 265 Yeasts 92 Morphology 73 Rhodotorula 287 Mycobacteria 124 RNA 109 Zidovudine 201 Rokitamycin 304 Netilmicin 431 Roxithromycin 252, 304 Neutropenia 136 RP7293 99 Nicotinamide 418 Rufloxacin 304 Non-small-cell lung cancer 144 -, in vitro activity 104 Norfloxacin 369 Subject Index